SCIO just might be worth considering. Company

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
SCIO just might be worth considering.

Company Background

Scio Diamond Technology Corporation (SCIO) focuses on engaging in man-made diamond technology development and commercialization. The Company has developed a technology through which single crystal diamond materials are produced through a chemical vapor deposition (CVD) process (the Diamond Technology). The Company focuses on the development of commercial production of its diamond materials for the industrial, technology and consumer applications. As of March 31, 2013, all of the Company's production capacity was sold for use in precision cutting devices. The Diamond Technology utilizes CVD growth technology to produce diamond crystals. This technology utilizes a manufacturing process for producing size diamond crystals. As of March 31, 2013, the Company grew an average of 57 crystals per growth run per diamond grower machine and averaging over three growth runs per month.

http://www.sciodiamond.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading